← All ComparisonsKRXKRX
blue-chip
Celltrion
068270VS
KB Financial Group
105560Bio growth stock vs financial dividend stock - returns vs stability
Celltrion
068270₩190,000
▲ 3,000 (+1.60%)
Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.
KB Financial Group
105560₩82,000
▲ 500 (+0.61%)
Korea's largest financial holding company. Comprehensive financial services centered on KB Kookmin Bank.
Key Metrics Comparison
Celltrion
Key Metrics Comparison
KB Financial Group
₩190,000
Price
₩82,000
+1.60%
Change
+0.61%
22.7
P/E Ratio
6.2
₩40.8조
Market Cap
₩33.2조
₩230,000
52W High
₩95,000
₩165,000
52W Low
₩68,000
1.3M
Volume
2.1M
About the Companies
Celltrion
Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.
KB Financial Group
Korea's largest financial holding company. Comprehensive financial services centered on KB Kookmin Bank.
※ All data is for reference only and not real-time. Investment decisions are the sole responsibility of the investor. This comparison is not investment advice.
Other Comparisons
Celltrion vs Samsung Biologics
Healthcare
KB Financial Group vs Samsung Life InsuranceFinance
KakaoBank vs KB Financial GroupFinance
Celltrion vs Eli Lilly & Co.Healthcare
KB Financial Group vs JPMorgan Chase & Co.Finance
Samsung Electronics vs Hyundai Motorblue-chip
Samsung Electronics vs Celltrionblue-chip
Samsung Electronics vs KB Financial Groupblue-chip
Samsung Electronics vs Kia Corporationblue-chip